Advertisement

InMode Ltd. INMD

Set alert

Price alert · INMD

All alert types
13.22 USD -0.29 -2.15%

At close · Oct 30

13.19 -0.03 -0.20%

After hours · Oct 30, 7:37 PM ET

Bid
13.21 × 2
Ask
13.22 × 2
13.19 Day range 13.60
12.76 52-week range 16.62
YTD
-10.01%
1 year
-10.13%
Open
13.60
Prev close
13.51
Mkt cap
760.73M
Vol
439.91K
Avg vol
465.98K
EPS
1.21
P/E
10.93
Div yield
0.00%
More statistics
Low
13.19
High
13.60
Forward P/E
7.35
Beta
2.09
Short ratio
3.99
Inst. own
56.97%
Dividend
0.00
Ex-div date
50-d avg
14.95
200-d avg
15.70
1y target
16.65

2Y chart

Chart tools
Interval

Events in this range
  • Feb 4, 2025Earnings: 0.42; estimate 0.5; surprise -16%
  • Apr 28, 2025Earnings: 0.31; estimate 0.33; surprise -6.06%
  • Apr 30, 2025Rating: Barclays · Overweight → Overweight
  • Jul 11, 2025Rating: Canaccord Genuity · Hold → Hold
  • Jul 30, 2025Earnings: 0.47; estimate 0.43; surprise 9.3%
  • Jul 30, 2025Rating: Barclays · Overweight → Overweight
  • Jul 30, 2025Rating: Needham · Hold → Hold
  • Oct 10, 2025Rating: Needham · Hold → Hold
  • Oct 10, 2025Rating: Canaccord Genuity · Hold → Hold
  • Nov 5, 2025Earnings: 0.38; estimate —; surprise —%
Signals (94)
NameDateAgo
MACD: Sell SignalOct 26, 20265 days ago
RSI: OversoldOct 26, 20265 days ago
MACD: Buy SignalOct 9, 20263 weeks ago
RSI: OversoldOct 6, 20263 weeks ago
RSI: OversoldOct 1, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 21, 20261 month ago
SMA: BearishSep 18, 20261 month ago
SMA: BearishSep 2, 20261 month ago
SMA: BullishSep 1, 20262 months ago
SMA: BearishAug 27, 20262 months ago
MACD: Sell SignalJul 23, 20263 months ago
SMA: BullishJun 24, 20264 months ago
SMA: BullishJun 24, 20264 months ago
MACD: Buy SignalJun 24, 20264 months ago
RSI: OverboughtJun 24, 20264 months ago
SMA: BearishMay 29, 20265 months ago
SMA: BullishMay 28, 20265 months ago
SMA: BearishMay 21, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BullishMay 7, 20265 months ago
SMA: BearishMay 6, 20265 months ago
MACD: Sell SignalApr 29, 20266 months ago
SMA: BearishApr 22, 20266 months ago
SMA: BullishApr 17, 20266 months ago
SMA: BullishApr 14, 20266 months ago
MACD: Buy SignalMar 17, 20267 months ago
RSI: OversoldMar 12, 20267 months ago
SMA: BearishFeb 23, 20268 months ago
SMA: BearishFeb 23, 20268 months ago
SMA: BullishFeb 19, 20268 months ago
SMA: BullishFeb 19, 20268 months ago
SMA: BearishFeb 10, 20268 months ago
MACD: Sell SignalFeb 9, 20268 months ago
SMA: BullishJan 26, 20269 months ago
SMA: BullishJan 26, 20269 months ago
MACD: Buy SignalJan 26, 20269 months ago
SMA: BearishJan 13, 20269 months ago
SMA: BullishJan 12, 20269 months ago
MACD: Sell SignalJan 9, 20269 months ago
SMA: BearishJan 8, 20269 months ago
SMA: BearishJan 8, 20269 months ago
RSI: OverboughtJan 6, 20269 months ago
SMA: BullishJan 5, 20269 months ago
SMA: BullishDec 26, 202510 months ago
MACD: Buy SignalNov 28, 202511 months ago
SMA: BearishOct 29, 20251 year ago
MACD: Sell SignalOct 24, 20251 year ago
SMA: BearishOct 22, 20251 year ago
SMA: BullishOct 20, 20251 year ago
MACD: Buy SignalOct 20, 20251 year ago
MACD: Sell SignalOct 16, 20251 year ago
SMA: BearishOct 10, 20251 year ago
SMA: BullishOct 9, 20251 year ago
MACD: Buy SignalOct 9, 20251 year ago
MACD: Sell SignalOct 8, 20251 year ago
MACD: Buy SignalOct 2, 20251 year ago
MACD: Sell SignalSep 19, 20251 year ago
MACD: Buy SignalSep 18, 20251 year ago
MACD: Sell SignalSep 17, 20251 year ago
SMA: BullishSep 5, 20251 year ago
MACD: Buy SignalSep 5, 20251 year ago
SMA: BearishSep 4, 20251 year ago
MACD: Sell SignalSep 4, 20251 year ago
SMA: BullishSep 3, 20251 year ago
SMA: BearishSep 2, 20251 year ago
SMA: BullishAug 22, 20251 year ago
SMA: BearishAug 19, 20251 year ago
SMA: BullishAug 13, 20251 year ago
MACD: Buy SignalAug 13, 20251 year ago
SMA: BearishAug 8, 20251 year ago
SMA: BullishAug 7, 20251 year ago
SMA: BearishJul 29, 20251 year ago
MACD: Sell SignalJul 29, 20251 year ago
MACD: Buy SignalJul 25, 20251 year ago
SMA: BullishJul 22, 20251 year ago
MACD: Sell SignalJul 16, 20251 year ago
SMA: BearishJul 15, 20251 year ago
SMA: BullishJun 30, 20251 year ago
MACD: Buy SignalJun 25, 20251 year ago
MACD: Sell SignalJun 13, 20251 year ago
MACD: Buy SignalMay 1, 20251 year ago
MACD: Sell SignalApr 30, 20251 year ago
MACD: Buy SignalApr 23, 20251 year ago
RSI: OversoldApr 10, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
SMA: BearishMar 28, 20251 year ago
MACD: Sell SignalFeb 27, 20251 year ago
RSI: OverboughtFeb 19, 20251 year ago
SMA: BullishFeb 5, 20251 year ago
MACD: Buy SignalJan 17, 20251 year ago
MACD: Sell SignalJan 8, 20251 year ago
MACD: Buy SignalJan 7, 20251 year ago
RSI: OverboughtNov 25, 20241 year ago

Key statistics

Market cap
985.43M
Enterprise value
508.08M
Trailing P/E
6.55
Forward P/E
7.35
PEG ratio
0.00
Price / sales
2.45
Price / book
1.57
EPS (TTM)
2.38
Beta
2.09
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
44.50%
Revenue (TTM)
401.56M
Revenue growth
10.60%
Free cash flow
39.67M
Total cash
510.68M
Total debt
6.10M
Return on equity
25.91%
Shares outstanding
63.21M
Short % of float
5.33%
50-day average
14.95
200-day average
15.70

Analyst view

Consensus: hold

Hold
Price target (mean) 16.65 +25.9% upside
Target (low)
14.00
Target (mean)
16.65
Target (high)
21.00
Ratings (0m) 7 1 buy · 6 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold6
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.35499.

Earnings history

Financials — quick view

All financials
INMD Revenue — quarterly 95.59M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
INMD Net income — quarterly 17.06M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
INMD EPS — quarterly 0.29
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

INMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2025Sep 1, 2025—0.38——
Jul 30, 2025Jun 1, 20250.430.47+0.04+9.30%
Apr 28, 2025Mar 1, 20250.330.31-0.02-6.06%
Feb 4, 2025Dec 1, 20240.500.42-0.08-16.00%
Oct 30, 2024Sep 1, 20240.570.70+0.13+22.81%

Upgrades / downgrades

INMD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 10, 2025Canaccord GenuitymainHoldHold
Oct 10, 2025NeedhamreitHoldHold
Jul 30, 2025NeedhamreitHoldHold
Jul 30, 2025BarclaysmainOverweightOverweight
Jul 11, 2025Canaccord GenuitymainHoldHold
Apr 30, 2025BarclaysmainOverweightOverweight

About InMode Ltd.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Sector
Healthcare
Industry
Medical Devices
Country
Israel
Website
inmodemd.com

News

Your note

Sign in to keep a note on INMD — it syncs with the Stock Master app.

Institution ownership

INMD institution ownership
Holder% heldSharesValueReported
Renaissance Technologies, LLC3.68%2,326,51836.27MJun 29, 2025
Blackrock Inc.3.63%2,294,73235.77MJun 29, 2025
Doma Perpetual Capital Management LLC3.54%2,239,32334.91MJun 29, 2025
LSV Asset Management3.07%1,939,06730.23MJun 29, 2025
Meitav Investment House Ltd.2.09%1,323,20520.63MJun 29, 2025
Millennium Management Llc1.95%1,233,06519.22MJun 29, 2025

Fund ownership

INMD fund ownership
Holder% heldSharesValueReported
Boston Trust Walden Funds-Boston Trust Walden Small Cap Fund0.86%546,3998.52MJun 29, 2025
iShares Trust-iShares Core MSCI EAFE ETF0.77%487,0787.59MAug 30, 2025
JPMorgan Trust I-JPMorgan Small Cap Blend Fund0.53%338,0945.27MJun 29, 2025
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund0.52%329,5095.14MMay 30, 2025
HOTCHKIS & WILEY Fd.S/DE/-Hotchkis & Wiley Small Cap Diversified Value0.30%187,8002.93MJun 29, 2025
iShares Trust-iShares Core MSCI Total International Stock ETF0.29%185,0682.89MAug 30, 2025
Advertisement